Kidney Cancer Drugs Market Share, Trends And Growth To 2020: Grand View Research, Inc

The increasing incidences of lifestyle based diseases due to excessive drinking and smoking habits coupled with rising incidences of chronic diseases such as kidney tumors and kidney cancer has led to growth in the kidney cancer drugs market. The increasing geriatric population base globally is also the factor expected to further boost the growth of this market as they are more prone to chronic diseases. Additionally, the patients as well as clinicians prefer kidney cancer drugs over the targeted therapies. For the advanced stage metastatic tumor patients, cancer drugs are life saving and prolonging treatment regimens.

Nexavar is expected to have the largest share in the market owing to its common usage in several diseases during the forecast period. The different brands used as kidney cancer drugs are Inlyta (Axitnib), Nexavar (Sorafebin), Afinitor (Everolimus), Avastin (Bevaciazumab), Votrient (Pazopanib), Torisel (temosirolimus), Sutent and Proleukin (Interlukin-2/ Aldesleukin).

View summary of this report, click the link:


It also combines the pipeline analysis for various potential drugs which are currently in phase II and phase III trials.. On the basis of region, the North America dominates the kidney cancer drugs market. The largest share of this region is due to the rising incidences of cancer and other kidney diseases. However, Asia Pacific is expected to witness a huge rise in the market share due to the low costs of drug production and increasing renal cell carcinoma patient base in this region.

Various companies are creating their marketing strategies such as collaborations, expansions and new innovations to maintain their market share in the kidney cancer drugs market. The actively participating key players in the kidney cancer drugs market include Hoffman La Roche, Bayer Pharma AG, Glaxosmith, plc., Pfizer Inc., and Novartis AG.

The report Kidney Cancer Drugs Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020 is available now to Grand View Research customers and can also be purchased directly at


About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit Grand View Research



Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058
Toll Free: 1-888-202-9519

Email:  [email protected]

Blog Site: